Triple Combination Therapy in High Risk Crohn's Disease (CD)

Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis

A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease

Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease

Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease

Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease

An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies

AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH

A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ)

A Study of Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnormalities